Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK)
HKD 16.78
(0.96%)
HKD 16.78
(0.96%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 11.95 Billion CNY | 4.56% |
| 2022 | 11.42 Billion CNY | 15.17% |
| 2021 | 9.92 Billion CNY | 3.8% |
| 2020 | 9.56 Billion CNY | 43.78% |
| 2019 | 6.64 Billion CNY | 1.94% |
| 2018 | 6.52 Billion CNY | 15138.7% |
| 2017 | 42.8 Million CNY | -27.1% |
| 2016 | 58.71 Million CNY | -91.23% |
| 2015 | 669.43 Million CNY | 19.43% |
| 2014 | 560.53 Million CNY | 8.15% |
| 2013 | 518.27 Million CNY | 528.46% |
| 2012 | 82.46 Million CNY | -43.1% |
| 2011 | 144.92 Million CNY | 272.88% |
| 2010 | 38.86 Million CNY | -38.67% |
| 2009 | 63.36 Million CNY | -76.81% |
| 2008 | 273.27 Million CNY | -71.43% |
| 2007 | 956.48 Million CNY | 7.69% |
| 2006 | 888.19 Million CNY | -3.22% |
| 2005 | 917.78 Million CNY | -16.16% |
| 2004 | 1.09 Billion CNY | 36.59% |
| 2003 | 801.41 Million CNY | 24.25% |
| 2002 | 645.02 Million CNY | 45.71% |
| 2001 | 442.68 Million CNY | -23.28% |
| 2000 | 577 Million CNY | -13.59% |
| 1999 | 667.75 Million CNY | -4.1% |
| 1998 | 696.26 Million CNY | -16.58% |
| 1997 | 834.63 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 13.88 Billion CNY | 0.59% |
| 2024 Q3 | 12.05 Billion CNY | -9.46% |
| 2024 Q1 | 13.8 Billion CNY | 15.5% |
| 2023 Q4 | 11.95 Billion CNY | -2.68% |
| 2023 Q3 | 12.27 Billion CNY | -4.98% |
| 2023 Q1 | 13.02 Billion CNY | 13.92% |
| 2023 FY | 11.95 Billion CNY | 4.56% |
| 2023 Q2 | 12.92 Billion CNY | -0.76% |
| 2022 Q3 | 11.29 Billion CNY | 3.63% |
| 2022 FY | 11.42 Billion CNY | 15.17% |
| 2022 Q4 | 11.42 Billion CNY | 1.19% |
| 2022 Q2 | 10.89 Billion CNY | -2.42% |
| 2022 Q1 | 11.17 Billion CNY | 12.56% |
| 2021 Q4 | 9.92 Billion CNY | -6.39% |
| 2021 Q2 | 11.79 Billion CNY | 10.07% |
| 2021 FY | 9.92 Billion CNY | 3.8% |
| 2021 Q3 | 10.6 Billion CNY | -10.12% |
| 2021 Q1 | 10.71 Billion CNY | 12.08% |
| 2020 Q1 | 9.74 Billion CNY | 46.57% |
| 2020 Q3 | 9.1 Billion CNY | 2.63% |
| 2020 Q2 | 8.87 Billion CNY | -8.98% |
| 2020 FY | 9.56 Billion CNY | 43.78% |
| 2020 Q4 | 9.56 Billion CNY | 5.01% |
| 2019 Q2 | 8.25 Billion CNY | 4.35% |
| 2019 Q1 | 7.91 Billion CNY | 21.29% |
| 2019 FY | 6.64 Billion CNY | 1.94% |
| 2019 Q3 | 7.85 Billion CNY | -4.83% |
| 2019 Q4 | 6.64 Billion CNY | -15.37% |
| 2018 FY | 6.52 Billion CNY | 15138.7% |
| 2018 Q4 | 6.52 Billion CNY | -15.82% |
| 2018 Q3 | 7.74 Billion CNY | -2.36% |
| 2018 Q2 | 7.93 Billion CNY | 32917.54% |
| 2018 Q1 | 24.03 Million CNY | -43.85% |
| 2017 Q3 | 43.37 Million CNY | 0.06% |
| 2017 Q4 | 42.8 Million CNY | -1.3% |
| 2017 FY | 42.8 Million CNY | -27.1% |
| 2017 Q2 | 43.34 Million CNY | -17.23% |
| 2017 Q1 | 52.37 Million CNY | -10.81% |
| 2016 Q3 | 295.6 Million CNY | -42.93% |
| 2016 Q1 | 625.42 Million CNY | -6.57% |
| 2016 FY | 58.71 Million CNY | -91.23% |
| 2016 Q4 | 58.71 Million CNY | -80.14% |
| 2016 Q2 | 517.94 Million CNY | -17.19% |
| 2015 Q2 | 670.27 Million CNY | 10.83% |
| 2015 FY | 669.43 Million CNY | 19.43% |
| 2015 Q4 | 669.43 Million CNY | -3.53% |
| 2015 Q3 | 693.93 Million CNY | 3.53% |
| 2015 Q1 | 604.75 Million CNY | 7.89% |
| 2014 Q1 | 529.97 Million CNY | 2.26% |
| 2014 Q4 | 560.53 Million CNY | -7.49% |
| 2014 FY | 560.53 Million CNY | 8.15% |
| 2014 Q3 | 605.89 Million CNY | 20.71% |
| 2014 Q2 | 501.96 Million CNY | -5.29% |
| 2013 Q3 | 536 Million CNY | -12.68% |
| 2013 Q4 | 518.27 Million CNY | -3.31% |
| 2013 FY | 518.27 Million CNY | 528.46% |
| 2013 Q1 | 77.5 Million CNY | -6.02% |
| 2013 Q2 | 613.83 Million CNY | 692.04% |
| 2012 Q3 | 165.16 Million CNY | 19.98% |
| 2012 Q4 | 82.46 Million CNY | -50.07% |
| 2012 Q1 | 152.07 Million CNY | 4.93% |
| 2012 FY | 82.46 Million CNY | -43.1% |
| 2012 Q2 | 137.66 Million CNY | -9.48% |
| 2011 Q3 | 134.03 Million CNY | 58.78% |
| 2011 FY | 144.92 Million CNY | 272.88% |
| 2011 Q4 | 144.92 Million CNY | 8.12% |
| 2011 Q2 | 84.41 Million CNY | 54.73% |
| 2011 Q1 | 54.55 Million CNY | 40.37% |
| 2010 Q2 | 27.4 Million CNY | -53.05% |
| 2010 Q3 | 41.07 Million CNY | 49.9% |
| 2010 Q4 | 38.86 Million CNY | -5.38% |
| 2010 Q1 | 58.36 Million CNY | -7.89% |
| 2010 FY | 38.86 Million CNY | -38.67% |
| 2009 FY | 63.36 Million CNY | -76.81% |
| 2009 Q1 | 238.34 Million CNY | -12.78% |
| 2009 Q2 | 151.28 Million CNY | -36.53% |
| 2009 Q3 | 59.34 Million CNY | -60.77% |
| 2009 Q4 | 63.36 Million CNY | 6.79% |
| 2008 Q3 | 289.18 Million CNY | -55.65% |
| 2008 Q2 | 652.05 Million CNY | 39.17% |
| 2008 Q1 | 468.54 Million CNY | -51.01% |
| 2008 Q4 | 273.27 Million CNY | -5.5% |
| 2008 FY | 273.27 Million CNY | -71.43% |
| 2007 Q1 | 970.44 Million CNY | 9.26% |
| 2007 FY | 956.48 Million CNY | 7.69% |
| 2007 Q4 | 956.48 Million CNY | -2.19% |
| 2007 Q3 | 977.91 Million CNY | 0.65% |
| 2007 Q2 | 971.63 Million CNY | 0.12% |
| 2006 Q3 | 867.76 Million CNY | -0.42% |
| 2006 Q2 | 871.44 Million CNY | -1.76% |
| 2006 FY | 888.19 Million CNY | -3.22% |
| 2006 Q1 | 887.08 Million CNY | -3.35% |
| 2006 Q4 | 888.19 Million CNY | 2.35% |
| 2005 Q4 | 917.78 Million CNY | 1.04% |
| 2005 Q3 | 908.37 Million CNY | -12.28% |
| 2005 Q2 | 1.03 Billion CNY | -2.55% |
| 2005 Q1 | 1.06 Billion CNY | -2.93% |
| 2005 FY | 917.78 Million CNY | -16.16% |
| 2004 Q3 | 899.3 Million CNY | 7.53% |
| 2004 Q4 | 1.09 Billion CNY | 21.72% |
| 2004 Q2 | 836.3 Million CNY | 4.28% |
| 2004 FY | 1.09 Billion CNY | 36.59% |
| 2004 Q1 | 801.97 Million CNY | 0.07% |
| 2003 Q2 | 667.72 Million CNY | 0.08% |
| 2003 Q3 | 712.98 Million CNY | 6.78% |
| 2003 Q4 | 801.41 Million CNY | 12.4% |
| 2003 FY | 801.41 Million CNY | 24.25% |
| 2003 Q1 | 667.17 Million CNY | 3.43% |
| 2002 Q4 | 645.02 Million CNY | 26.15% |
| 2002 Q1 | 455.5 Million CNY | 2.9% |
| 2002 Q2 | 514.94 Million CNY | 13.05% |
| 2002 Q3 | 511.32 Million CNY | -0.7% |
| 2002 FY | 645.02 Million CNY | 45.71% |
| 2001 Q2 | 460.62 Million CNY | 0.0% |
| 2001 FY | 442.68 Million CNY | -23.28% |
| 2001 Q4 | 442.68 Million CNY | 0.0% |
| 2000 FY | 577 Million CNY | -13.59% |
| 2000 Q4 | 577 Million CNY | 0.0% |
| 1999 FY | 667.75 Million CNY | -4.1% |
| 1998 FY | 696.26 Million CNY | -16.58% |
| 1997 FY | 834.63 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 6.8 Million HKD | -175388.638% |
| Grand Pharmaceutical Group Limited | 3.4 Billion HKD | -251.056% |
| Extrawell Pharmaceutical Holdings Limited | 120.41 Million HKD | -9825.068% |
| Wai Yuen Tong Medicine Holdings Limited | 460.94 Million HKD | -2492.646% |
| Qianhai Health Holdings Limited | 487 Thousand HKD | -2453857.808% |
| Lee's Pharmaceutical Holdings Limited | 204.14 Million HKD | -5754.205% |
| Essex Bio-Technology Limited | 294.02 Million HKD | -3964.582% |
| Tongfang Kontafarma Holdings Limited | 333.82 Million HKD | -3479.973% |
| PuraPharm Corporation Limited | 424.77 Million HKD | -2713.47% |
| SSY Group Limited | 3.37 Billion HKD | -254.193% |
| JBM (Healthcare) Limited | 133.4 Million HKD | -8858.132% |
| Jacobson Pharma Corporation Limited | 749.37 Million HKD | -1494.757% |
| China Resources Pharmaceutical Group Limited | 85.84 Billion HKD | 86.079% |